Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 22 of 22 results for extracorporeal membrane oxygenation

  1. Extracorporeal membrane oxygenation in adults (IPG39)

    This guidance has been updated and replaced by NICE HealthTech guidance 260.

  2. Extra corporeal membrane oxygenation for acute heart failure in children

    Discontinued Reference number: GID-IP1153

  3. Extracorporeal membrane oxygenation (ECMO) in postneonatal children (IPG38)

    We have moved interventional procedures guidance 38 to become HealthTech guidance 17. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  4. Extracorporeal membrane oxygenation for severe acute respiratory failure in adults (IPG391)

    Interventional procedures, IPG391 - Issued: April 2011 --> We have moved interventional procedures guidance 391 to become HealthTech guidance 260. This is to better reflect the NICE HealthTech programme which combines the former NICE Diagnostics Assessment programme, Interventional Procedures programme and Medical Technologies Evaluation programme and to help you find relevant content more quickly. The guidance itself has not changed.

  5. Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (IPG482)

    This guidance has been updated and replaced by NICE interventional procedures guidance 807, 808 and 810.

  6. Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions (MIB89)

    NICE has developed a medtech innovation briefing (MIB) on Impella 2.5 for haemodynamic support during high-risk percutaneous coronary interventions .

  7. COVID-19 rapid guideline: managing COVID-19 (NG191)

    This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.